Key Dates
- Board meeting date: Thursday, November 5, 2026
- Period covered: Quarter and half year ended September 30, 2026
- Trading window closure period: September 16, 2026 to November 7, 2026 (both days inclusive)
Purpose of Board Meeting
The Board of Directors will consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2026.
Financial Impact
Financial impact not quantified in the disclosure. Results will be announced after board approval on November 5, 2026.
#Tags: #AstraZenecaPharmaIndia #Q2Results #SEBIDisclosure #RegulatoryCompliance #TradingWindowClosure #Neutral